An Excessive Increase In Glutamate Contributes To Glucose-Toxicity In Beta-Cells Via Activation Of Pancreatic Nmda Receptors In Rodent Diabetes

Xiao-Ting Huang,Chen Li,Xiang-Ping Peng,Jia Guo,Shao-Jie Yue,Wei Liu,Fei-Yan Zhao,Jian-Zhong Han,Yan-Hong Huang,Yang-Li,Qing-Mei Cheng,Zhi-Guang Zhou,Chen Chen,Dan-Dan Feng,Zi-Qiang Luo

DOI: https://doi.org/10.1038/srep44120

IF: 4.6

2017-01-01

Scientific Reports

Abstract:In the nervous system, excessive activation of NMDA receptors causes neuronal injury. Although activation of NMDARs has been proposed to contribute to the progress of diabetes, little is known about the effect of excessive long-term activation of NMDARs on beta-cells, especially under the challenge of hyperglycemia. Here we thoroughly investigated whether endogenous glutamate aggravated beta-cell dysfunction under chronic exposure to high-glucose via activation of NMDARs. The glutamate level was increased in plasma of diabetic mice or patients and in the supernatant of beta-cell lines after treatment with high-glucose for 72 h. Decomposing the released glutamate improved GSIS of beta-cells under chronic high-glucose exposure. Long-term treatment of beta-cells with NMDA inhibited cell viability and decreased GSIS. These effects were eliminated by GluN1 knockout. The NMDAR antagonist MK-801 or GluN1 knockout prevented high-glucose-induced dysfunction in beta-cells. MK-801 also decreased the expression of pro-inflammatory cytokines, and inhibited I-kappa B degradation, ROS generation and NLRP3 inflammasome expression in beta-cells exposed to high-glucose. Furthermore, another NMDAR antagonist, Memantine, improved beta-cells function in diabetic mice. Taken together, these findings indicate that an increase of glutamate may contribute to the development of diabetes through excessive activation of NMDARs in beta-cells, accelerating beta-cells dysfunction and apoptosis induced by hyperglycemia.